Abstract

The second messenger cAMP exerts powerful stimulatory effects on Ca(2+) signaling and insulin secretion in pancreatic beta-cells. Previous studies of beta-cells focused on protein kinase A (PKA) as a downstream effector of cAMP action. However, it is now apparent that cAMP also exerts its effects by binding to cAMP-regulated guanine nucleotide exchange factors (Epac). Although one effector of Epac is the Ras-related G protein Rap1, it is not fully understood what the functional consequences of Epac-mediated signal transduction are at the cellular level. 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate (8-pCPT-2'-O-Me-cAMP) is a newly described cAMP analog, and it activates Epac but not PKA. Here we demonstrate that 8-pCPT-2'-O-Me-cAMP acts in human pancreatic beta-cells and INS-1 insulin-secreting cells to mobilize Ca(2+) from intracellular Ca(2+) stores via Epac-mediated Ca(2+)-induced Ca(2+) release (CICR). The cAMP-dependent increase of [Ca(2+)](i) that accompanies CICR is shown to be coupled to exocytosis. We propose that the interaction of cAMP and Epac to trigger CICR explains, at least in part, the blood glucose-lowering properties of an insulinotropic hormone (glucagon-like peptide-1, also known as GLP-1) now under investigation for use in the treatment of type-2 diabetes mellitus.

Highlights

  • The second messenger cAMP exerts powerful stimulatory effects on Ca2؉ signaling and insulin secretion in pancreatic ␤-cells

  • RIP2-enhanced yellow fluorescent protein (EYFP) was incorporated into an adenoviral vector, and expression of EYFP was conferred to human ␤-cells by adenovirus-mediated gene transfer using AdRIP2EYFP (Fig. 1, C and D)

  • Confocal microscopy in combination with fluorescence immunocytochemistry demonstrated that expression of EYFP was restricted to the insulin-immunoreactive ␤-cells and not the glucagon-reactive ␣-cells in whole islets of Langerhans derived from rat (Fig. 2)

Read more

Summary

The abbreviations used are

Exchange protein activated by cAMP; PKA, protein kinase A; CICR, Ca2ϩ-induced Ca2ϩ release; FBS, fetal bovine serum; EYFP, enhanced yellow fluorescent protein; CRE, cAMP-response elements; TRITC, tetramethylrhodamine isothiocyanate; SES, standard extracellular saline; CREB, cAMP-response element-binding protein; IP3, inositol trisphosphate; RYR, ryanodine receptors; IP3-R, IP3 receptors; IP, inositol phosphate; ER, endoplasmic reticulum. Two isoforms of Epac have been described (Epac, Epac2) [1, 2], and each is proposed to mediate the PKA-independent signal transduction properties of cAMP. Recent structure-function analyses of cAMP action demonstrate that introduction of a 2Ј-methoxyl group in place of the 2Ј-hydroxyl group of cAMP confers Epac specificity to the cyclic nucleotide [4]. The properties of 8-pCPT-2Ј-O-Me-cAMP in living cells have been evaluated only with respect to its ability to promote Epac-mediated activation of Rap1 [4]. 8-pCPT-2Ј-O-Me-cAMP is likely to serve as a specific pharmacological tool for analyses of PKAindependent signaling properties of cAMP in the regulation of intracellular Ca2ϩ signaling and exocytosis

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call